AI-powered search
Try Polaris, our new AI-powered search!

What patient and disease characteristics do you consider when choosing a systemic therapy for patients with metastatic SCC?

Featuring Laura Ferris, MD, PhD |

Professor and Director of Clinical Trials, Dermatology
University of Pittsburgh
Pittsburgh, PA

| Published November 17, 2023

More from this series

Related Media

Powered by Polaris TM